首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   126105篇
  免费   9780篇
  国内免费   3636篇
耳鼻咽喉   988篇
儿科学   2330篇
妇产科学   1786篇
基础医学   7200篇
口腔科学   2878篇
临床医学   15077篇
内科学   18675篇
皮肤病学   2312篇
神经病学   6485篇
特种医学   4064篇
外国民族医学   40篇
外科学   12275篇
综合类   18372篇
现状与发展   23篇
一般理论   2篇
预防医学   5140篇
眼科学   2038篇
药学   11149篇
  73篇
中国医学   11105篇
肿瘤学   17509篇
  2024年   193篇
  2023年   2173篇
  2022年   3250篇
  2021年   5541篇
  2020年   5168篇
  2019年   4660篇
  2018年   4455篇
  2017年   4934篇
  2016年   5245篇
  2015年   5027篇
  2014年   9056篇
  2013年   11754篇
  2012年   7423篇
  2011年   7901篇
  2010年   6522篇
  2009年   6016篇
  2008年   5918篇
  2007年   6319篇
  2006年   5659篇
  2005年   5009篇
  2004年   4079篇
  2003年   3698篇
  2002年   3049篇
  2001年   2677篇
  2000年   2210篇
  1999年   1760篇
  1998年   1453篇
  1997年   1212篇
  1996年   1019篇
  1995年   920篇
  1994年   721篇
  1993年   558篇
  1992年   490篇
  1991年   452篇
  1990年   382篇
  1989年   333篇
  1988年   322篇
  1987年   279篇
  1986年   216篇
  1985年   258篇
  1984年   223篇
  1983年   165篇
  1982年   164篇
  1981年   163篇
  1980年   129篇
  1979年   121篇
  1978年   65篇
  1977年   42篇
  1976年   49篇
  1975年   32篇
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
141.
142.
143.
《Molecular therapy》2020,28(6):1432-1441
  1. Download : Download high-res image (155KB)
  2. Download : Download full-size image
  相似文献   
144.
145.
146.
147.
148.
149.

Background

Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.

Methods

Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.

Results

Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.

Conclusion

We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment.  相似文献   
150.
Introduction: Tamoxifen dominates the anti-estrogenic therapy in the early and metastatic breast cancer setting. Tamoxifen has a complex metabolism, being mainly metabolized by CYP2D6 into its 30–100 times more potent metabolite, endoxifen. Recently, a phase I study in which endoxifen as an orally z-endoxifen hydrochloride has been successfully evaluated.

Areas covered: the principal pharmacogenetic and non-genetic differences in the pharmacology of tamoxifen and endoxifen are evaluated. To this end, references from PubMed, Embase or Web of Science, among others, were reviewed As non-genetic factors, important differences and similarities such age, or adherence to tamoxifen therapy are comprehensively illustrated. Additionally, since CYP2D6 genotypes are considered the main limitation of tamoxifen, many studies have investigated the association between the worsened clinical outcomes in patients with non-functional CYP2D6 genotypes. In this review, an overview of the research on this field is presented. Also, a summary describing the literature about individualizing tamoxifen therapy with endoxifen concentrations and its limitations is listed.

Expert opinion: z-endoxifen hydrochloride is only investigated in the metastatic setting, still more research is required before its place in therapeutics is known. Similarly, monitoring tamoxifen efficacy based on endoxifen concentrations might not be overall recommended due to the limited evidence available.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号